The store will not work correctly when cookies are disabled.
3-{[4-(2-Methoxyphenyl)piperazin-1-yl]methyl}-5,7-dimethylimidazo[1,2-c]pyrimidine
ID: ALA563109
PubChem CID: 45272580
Max Phase: Preclinical
Molecular Formula: C20H25N5O
Molecular Weight: 351.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1N1CCN(Cc2cnc3cc(C)nc(C)n23)CC1
Standard InChI: InChI=1S/C20H25N5O/c1-15-12-20-21-13-17(25(20)16(2)22-15)14-23-8-10-24(11-9-23)18-6-4-5-7-19(18)26-3/h4-7,12-13H,8-11,14H2,1-3H3
Standard InChI Key: VGIPYYQGXWSQEJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
2.8059 -7.2029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8059 -8.0279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0914 -8.4404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0914 -6.7904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3769 -7.2029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3769 -8.0279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5923 -8.2828 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1074 -7.6154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5923 -6.9479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3374 -6.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4696 -5.9918 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7246 -5.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5315 -5.0357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0836 -5.6487 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8286 -6.4334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0217 -6.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8905 -5.4772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4426 -6.0903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2495 -5.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5045 -5.1342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9524 -4.5211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1455 -4.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5203 -8.4404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0914 -5.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5934 -4.0795 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7865 -4.2510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 6 1 0
1 2 1 0
5 4 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
6 7 2 0
7 8 1 0
17 18 2 0
8 9 2 0
18 19 1 0
9 5 1 0
19 20 2 0
4 1 2 0
20 21 1 0
9 10 1 0
21 22 2 0
22 17 1 0
14 17 1 0
5 6 1 0
2 23 1 0
10 11 1 0
4 24 1 0
11 12 1 0
22 25 1 0
2 3 2 0
25 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.45 | Molecular Weight (Monoisotopic): 351.2059 | AlogP: 2.68 | #Rotatable Bonds: 4 |
Polar Surface Area: 45.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.56 | CX LogP: 1.26 | CX LogD: 1.20 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -1.71 |
References
1. Linz S, Müller J, Hübner H, Gmeiner P, Troschütz R.. (2009) Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases., 17 (13): [PMID:19481941] [10.1016/j.bmc.2009.05.015] |